Combined Neoadjuvant Chemotherapy With Bevacizumab Improves Pathologic Complete Response in Patients With Hormone Receptor Negative Operable or Locally Advanced Breast Cancer.
- Resource Type
- Article
- Source
- American Journal of Clinical Oncology; Feb2015, Vol. 38 Issue 1, p74-79, 6p
- Subject
- Language
- ISSN
- 02773732